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Vitamin D: a novel player in endothelial function 
and dysfunction
Massimiliano Caprio, Caterina Mammi, Giuseppe M.C. Rosano
Vitamin D is produced endogenously in the skin after exposure to the
ultraviolet B spectrum of sunlight. Importantly, only few foods are natural
sources of a consistent amount of vitamin D. Consequently, vitamin D
insufficiency and deficiency are widespread among humans due to limit-
ed sun exposure and insufficient consumption of foods or beverages con-
taining vitamin D.
Vitamin D, as an inactive precursor, needs to undergo several steps to
be converted into the active form. First, in the liver, vitamin D is convert-
ed into 25-hydroxyvitamin D [25(OH)D]. This inactive precursor is of clin-
ical significance since it represents the standardized measure of the vita-
min D status. It is commonly recognized that plasma levels < 20 ng/ml are
insufficient [1]. 25(OH)D is then converted in the renal proximal tubule to
the active form calcitriol [1,25(OH)2D] whose levels are regulated by the
parathyroid hormone (PTH).
The primary physiological role of vitamin D in regulating calcium home-
ostasis is well established: hypovitaminosis D is known to contribute to
osteoporosis through a decline in calcium absorption, subsequent sec-
ondary hyperparathyroidism, and increased bone resorption. For this rea-
son, decreased vitamin D levels are usually associated with increased PTH
levels, and vitamin D supplementation significantly reduces PTH plasma
levels [2].
Importantly, vitamin D receptors are expressed by virtually all tissues,
including vascular smooth muscle cells and cardiomyocytes [3]. Therefore,
the attention of researchers has recently shifted towards finding a link
between hypovitaminosis D and cardiovascular diseases.
Several physiological mechanisms link vitamin D to hypertension
because calcitriol acts as an endogenous inhibitor of the Renin Angiotensin
System (RAS), finally determining intracellular calcium levels in vascular
smooth muscle cells. Mice lacking vitamin D receptor show excessive plas-
ma renin activity with associated hypertension [4]. Interestingly, such
observations have also been confirmed in human disease, with cross-sec-
tional studies demonstrating higher levels of calcitriol associated with low-
er plasma renin activity [5]. However, only observational studies support
a link between vitamin D levels and blood pressure, whereas there are no
interventional studies confirming a potential effect of vitamin D supple-
mentation on blood pressure. 
Endothelial dysfunction represents an early event in cardiovascular 
diseases which is relatively easy to assess nowadays. It is worthy to note 
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that both observational and interventional studies
have established an association between vitamin
D levels and endothelial dysfunction. In a small
cohort of young asymptomatic patients, flow medi-
ated dilatation (FMD) measurements were signifi-
cantly lower in 25(OH)D-deficient subjects than con-
trols, and improved after acute treatment with
calcitriol [6]. Moreover, vitamin D negatively corre-
lated with brachial artery FMD also in pathological
conditions, as shown in a large cohort of patients
affected by type 2 diabetes.
The study published in Archives of Medical 
Science [7] was designed to address whether
25(OH)D plasma levels in normotensive women
were associated with vasodilator function of the
endothelium, as assessed by reactive hyperaemia
index (RHI). 
The authors studied a homogeneous, although
quite small, group of healthy, normotensive, non-
smoking, normolipidaemic and normoglycaemic
women, who were classified according their plas-
ma levels of 25(OH)D. This represents to original
subset of patients, with no interference of con-
founding elements such as smoking, medications
or pre-existing cardiovascular abnormalities. In addi-
tion, endothelial function was evaluated through
reactive hyperaemia index (RHI), assessed by digi-
tal (fingertip) peripheral arterial tonometry (PAT),
a validated operator-independent technique [8]. 
It is important to note that the vasodilator response
following transient regional ischaemia is a well
established measure of vascular function both in
brachial artery and in digital microcirculation,
although the two vascular beds may reflect distinct
aspects of vascular function.
In accordance with pre-existing literature, RHI
was significantly lower in subjects deficient for vita-
min D than in controls, and serum 25(OH)D levels
emerged as the best positive predictor for RHI. Sur-
prisingly, diastolic blood pressure turned out to be
significantly lower in the low vitamin D group, dif-
ferently from what would have been expected.
However, caution is advised in interpreting these
results, considering the relatively small study group.
Also, as the authors themselves stated, blood 
pressure measurements were not based on 24-h
registration. The question arises whether the
menopausal or post-menopausal status could have
revealed different outcomes in endothelial function
during the follow up of the same patients. It
appears that all the patients studied were pre-
menopausal, even if the authors did not explicitly
clarify this important aspect. Given the relatively
narrow range of age, which was close to the
menopausal transition, it would be extremely inter-
esting to evaluate potential differences in deterio-
ration of endothelial function related to the vita-
min D status [9]. 
In conclusion, a large body of evidence suggests
a link between vitamin D and cardiovascular dis-
eases, but available data are still insufficient to con-
clude that low levels of vitamin D lead to an
increased cardiovascular risk, especially in view of
the fact that most of the data are based on obser-
vational studies. Vitamin D supplementation stud-
ies conducted so far are mainly equivocal. For this
reason, recent guidelines published by the
Endocrine Society do not recommend screening for
vitamin D insufficiency for cardiovascular protec-
tion [10]. Large randomized clinical trials with vita-
min D, which have recently started, have as their
primary endpoint the evaluation of cardiovascular
outcome. Hopefully, several years will be enough
to establish a real causal link between the vitamin D
status and cardiovascular risk, and to finally shed
more light on the pathophysiology of endothelial
dysfunction in relation to the vitamin D status.
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